Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05037292 · ClinicalTrials.gov registry record · NA
PAtient-centered mUltidiSciplinary Care for vEterans Undergoing Surgery (PAUSE)
A NA study of Frailty, sponsored by VA Office of Research and Development.
- Active
- Registry status
- NA
- Development phase
- 35,015
- Enrollment target
- 3
- Study locations
NCT05037292: Active NA study of Frailty, sponsored by VA Office of Research and Development.
NCT05037292 is a NA study of Frailty that is active but no longer recruiting, run by VA Office of Research and Development. The registered enrollment target is 35,015 participants, above the 777-participant average among 48 other Frailty trials with a reported enrollment target (4406% higher). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05037292, a NA study of Frailty, is active but no longer recruiting, sponsored by VA Office of Research and Development.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 35,015 participants
- Enrollment target
- 3
- Study locations
Study Summary
The PAUSE Trial is a pragmatic, randomized clinical trial for Veterans scheduled for elective surgery at 3 large VA facilities (Palo Alto, Houston, and Nashville). The PAUSE Trial focuses on cooperation between providers of various disciplines in order to provide better care. Veterans identified as frail upon standardized will be referred to a multidisciplinary "PAUSE Board" comprised of members from surgery, anesthesia, geriatrics, palliative care, case management, rehabilitation, and nutrition. Diverse specialists will come together in a team environment to discuss care options, scientific evidence, and patient goals and expectations, creating individual patient recommendations. The investigators hypothesize that the PAUSE Board model will improve quality and outcomes by promoting guidelines and evidence-based care recommendations as well as constructive team-based discussions to align care with patient goals and expectations.
Primary Outcome
The rate of mortality at or within 180 days after the elective surgery
Conditions Studied
Interventions
- OTHER PAUSE Intervention
Study Locations (3)
California
- VA Palo Alto Health Care System, Palo Alto, CA - Palo Alto
Tennessee
- Tennessee Valley Healthcare System Nashville Campus, Nashville, TN - Nashville
Texas
- Michael E. DeBakey VA Medical Center, Houston, TX - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35,015 participants |
| Start Date | 2021-10-26 |
| Est. Completion | 2026-09-30 |
| Phase | NA |
What the registry record for NCT05037292 still lists
NCT05037292 is an interventional study that assigns participants to a tested intervention. Its 35,015 participants enrollment target places it among the larger protocols in the corpus, above the 777-participant average among 48 other Frailty trials with a reported enrollment target (4406% higher).
The record links to 1 condition, with Frailty appearing as the primary indexed condition, and to 1 intervention - of which PAUSE Intervention is the first listed.
NCT05037292 reports a single indexed study location in California, Tennessee, Texas.
Frequently Asked Questions
What is clinical trial NCT05037292 about?
NCT05037292 is a clinical study titled "PAtient-centered mUltidiSciplinary Care for vEterans Undergoing Surgery (PAUSE)". The PAUSE Trial is a pragmatic, randomized clinical trial for Veterans scheduled for elective surgery at 3 large VA facilities (Palo Alto, Houston, and Nashville). The PAUSE Trial focuses on cooperation between providers of various disciplines in order to provide better care. Veterans identified as ...
What is the current status of trial NCT05037292?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 35,015 participants. The study started on 2021-10-26. Estimated completion is 2026-09-30.
What conditions does trial NCT05037292 study?
This clinical trial studies the following conditions: Frailty.
What interventions are being tested in trial NCT05037292?
The interventions under investigation include: PAUSE Intervention (OTHER).
Who is sponsoring clinical trial NCT05037292?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05037292 being conducted?
This trial has 3 study locations across California, Tennessee, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Frailty
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05037292's enrollment target sits among peer trials
35,015 1st of 48 higher than 48 of 48 other Frailty trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Frailty trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Partnered Evaluation to Improve the Identification and Management of Functional Impairment and Frailty Among Older Veterans in Primary Care Settings
RECRUITING · NA
-
Occupational Therapy and Registered Dietitian Services to Reduce Fall Risk Among Home Delivered Meal Clients
RECRUITING · NA
-
Evaluate the Impact of Targeted Physical Activity on Clinically Debilitated Dialysis Patients.
RECRUITING · NA
-
Assisted Ambulation to Improve Health Outcomes for Older Medical Inpatients
RECRUITING · NA
-
Meal Delivery and Exercise
RECRUITING · NA
-
Nicotinamide Mononucleotide Supplementation for Exercise Tolerance Improvement in Healthy Older Adults
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02225301 · 35,000 participants · NA
iLookOut for Child Abuse -Online Learning Module for Early Childcare Providers
- NCT03720613 · 34,532 participants
Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced Constipation
- NCT03262259 · 36,000 participants · NA
Evaluation of Global Smart Drinking Goals Initiative
- NCT07150923 · 36,503 participants · NA
Supraglottic Airway for Resuscitation Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI